药物诱导的QT延长:瑞典临床决策支持系统中的风险分类与临床结果之间的关联.
Ola Nordqvist1,2, Olof Björneld1,3,4, Patrick Bergman1,3
1Department of Medicine and Optometry, eHealth Institute, Faculty of Health and Life Sciences, Linnaeus University, Kalmar, Sweden.
Clinical pharmacology and therapeutics
|November 10, 2025
概括
临床决策支持系统 (CDSS) 可以标记药物风险. 瑞典的CDSS验证显示了QT延长药物风险水平与心室失常等不良事件之间的关联,尽管需要多因素算法.
科学领域:
- 药物监督 药物监督 药物监督
- 临床信息学 临床信息学
- 心脏病学 心脏病学
背景情况:
- 临床决策支持系统 (CDSS) 有助于识别潜在的药物不良事件.
- 药物诱导的QT延长具有显著的心血管风险.
研究的目的:
- 通过评估其QT延长药物的风险分类来验证瑞典CDSS的Janusmed风险概况.
- 调查CDSS计算的风险水平与注册的临床结果之间的关联.
主要方法:
- 使用瑞典电子健康记录 (2011-2020) 的回顾性队列研究.
- 包括188,453名暴露于QT延长药物的受试者 (风险级别I-III) 和匹配的对照 (风险级别0).
- 经对共变量调整后的后勤回归分析,以评估包括心室节律失常,Torsade de Pointes,心脏骤停和死亡在内的结果.
主要成果:
- 与对照组 (0,17%) 相比,在CDSS风险分类较高的受试者中观察到更高的腹腔失常率 (I级:0.26%,II级:0.34%,III级:0.71%).
- 经过对混因素的调整后,III级风险仍然与不良结果显著相关 (OR 2.1,95% CI 1.6-2.9).
- 其他临床结果显示了类似的趋势,表明CDSS风险和不良事件之间的相关性.
结论:
- 虽然CDSS显示QT延长药物风险分类与临床结果之间存在关联,但绝对受影响个体数量很少.
- 伴随因素,特别是先前的诊断,显著影响患者的风险,突出需要更全面的风险评估.
- 开发多因素CDSS算法对于准确识别高风险患者和有效指导临床实践至关重要.
更多相关视频
相关概念视频
Therapeutic Drug Monitoring: Overview and Classification
282
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
282
Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Factors Affecting Drug Response: Overview
2.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.9K


